comparemela.com
Home
Live Updates
Late Breaking Abstract Session - Breaking News
Pages:
Latest Breaking News On - Late breaking abstract session - Page 2 : comparemela.com
ImmunoGen Announces Results from the Phase 3 MIRASOL Trial Selected as Late-Breaking Presentation for ASCO 2023 Annual Meeting
WALTHAM, Mass. (BUSINESS WIRE) May 9, 2023
University of oklahoma
United states
Kathleen moore
Anna berkenblit
Courtney okonek
Robert stanislaro
David omalley
Mirvetuximab soravtansine
Pivekimab sunirine
Anabel chan
Clinical research
Exchange commission
Department of leukemia
Immunogen inc
James cancer center
American society of clinical oncology
Sanofi - Aventis Groupe: Data from two Phase 3 studies demonstrating fitusiran significantly reduced bleeds in people with hemophilia A or B, with or without inhibitors, were featured at ASH s plenary and late-breaking sessions
Data from two Phase 3 studies demonstrating fitusiran significantly reduced bleeds in people with hemophilia A or B, with or without inhibitors, were featured at ASH's plenary and late-breaking
France general
United states
Eva schaefer jansen
Arnaud delepine
Felix lauscher
Nathalie pham
Dietmar berger
Sally bain
American society of hematology
Global head of development
Alnylam pharmaceutical inc
American society
Late breaking abstract session
Plenary scientific session
Global head
Alnylam pharmaceutical
vimarsana © 2020. All Rights Reserved.